The renin-angiotensin-aldosterone system (RAAS), or renin-angiotensin-system (RAS) is a regulator of blood pressure and cardiovascular function. Dysregulated RAAS is implicated in high blood pressure, ...
Renin-angiotensin-aldosterone system inhibitors were linked to better pediatric chronic kidney disease outcomes compared with calcium channel blockers, according to study data published in JAMA ...
EurekAlert!: Transcription factors in the associative gene network of the renin-angiotensin-aldosterone system in humans
Empirical and theoretical studies can be distinguished among the areas of investigation of the renin-angiotensin-aldosterone system (RAAS) and its relationship with the development of cardiovascular ...
Transcription factors in the associative gene network of the renin-angiotensin-aldosterone system in humans
Multiple recent studies highlight the renin-angiotensin-aldosterone system (RAAS) as a critical factor in COVID-19 severity, with ACE2 dysregulation influencing inflammation, vascular damage, and ...
Medscape: Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work?
Inhibition of the Renin Angiotensin Aldosterone System in Black Populations -- Does It or Doesn't It Work?
ascopubs.org: The impact of renin-angiotensin-aldosterone system inhibitors on immune checkpoint inhibitor-associated adverse cardiovascular events.
The impact of renin-angiotensin-aldosterone system inhibitors on immune checkpoint inhibitor-associated adverse cardiovascular events.
A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).
JSTOR Daily: RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND THROMBOXANE A₂/PROSTACYCLIN IN NORMOTENSIVE AND HYPERTENSIVE BLACK ZIMBABWEANS
The New England Journal of Medicine: Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
The New England Journal of Medicine: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
News Medical: Umbrella analysis of the effect of renin-angiotensin-aldosterone system inhibitors on COVID-19 related outcomes